BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grattagliano I, Ubaldi E, Portincasa P. Drug-induced enterocolitis: Prevention and management in primary care. J Dig Dis. 2018;19:127-135. [PMID: 29417737 DOI: 10.1111/1751-2980.12585] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Petitpain N, D'Amico F, Yelehe-Okouma M, Jouzeau JY, Netter P, Peyrin-Biroulet L, Gillet P. IL-17 Inhibitors and Inflammatory Bowel Diseases: A Postmarketing Study in Vigibase. Clin Pharmacol Ther 2021;110:159-68. [PMID: 33411953 DOI: 10.1002/cpt.2155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 Mori F, Liccioli G, Fuchs O, Barni S, Giovannini M, Sarti L, Novembre E, Caubet JC. Drug-induced enterocolitis syndrome: Similarities and differences compared with food protein-induced enterocolitis syndrome. Pediatr Allergy Immunol 2021;32:1165-72. [PMID: 33651420 DOI: 10.1111/pai.13491] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sachar DB. Small Bowel Lesions Mimicking Crohn's Disease. Curr Gastroenterol Rep 2018;20:43. [PMID: 30079433 DOI: 10.1007/s11894-018-0651-8] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Hewlings S, Kalman D. A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, and Gastrointestinal Disorders. Nutrients 2020;12:E665. [PMID: 32121367 DOI: 10.3390/nu12030665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kato M, Sasaki S, Nakamura T, Kurokawa K, Yamada T, Ochi Y, Ihara H, Takahashi F, Takahashi K. Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis. Sci Rep 2019;9:12062. [PMID: 31427707 DOI: 10.1038/s41598-019-48593-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
6 Brechmann T, Günther K, Neid M, Schmiegel W, Tannapfel A. Triggers of histologically suspected drug-induced colitis. World J Gastroenterol 2019; 25(8): 967-979 [PMID: 30833802 DOI: 10.3748/wjg.v25.i8.967] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
7 Wang D, Li D, Zhang Y, Chen J, Zhang Y, Liao C, Qin S, Tian Y, Zhang Z, Xu F. Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage. Acta Pharm Sin B 2021;11:763-80. [PMID: 33777681 DOI: 10.1016/j.apsb.2020.07.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Brechmann T, Günther K, Neid M, Tannapfel A, Schmiegel W. Phenotype of histologically suspected drug-induced colitis; results of a comparative, retrospective cohort study. Scand J Gastroenterol 2019;54:855-62. [PMID: 31215277 DOI: 10.1080/00365521.2019.1630674] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]